crispr tech. crsp long entry, fib and std dev channel
why not to double check for assured profit before you pay a dime Easy line to follow and simple chart be your guide here , it works for a week in #trade
- potential aim for takover (I suppose by VRTX ) . Company has 2.5B in cash, no debt with market cap about 4.5B$ (EV = 2.0 B) - solid pipeline and probably will be first who get FDA approval for commercial CRISPR product - got most of up front payment for milestones in CRISPR among competitors ( about 1b$ from Vertex and collaboration with Bayer). BEAM for example...
1) Crisper has a lot of cash on hand to survive through tightening of QE and fund pipeline without dilution 2) Potential takeover by $VRTX or other compamy at current prices VERY possible.
With more advances in gene-tech to come - This is my Bet.
CRSP has hit a major support level for the 4th time since IPO.
CRISPR THERAPEUTICS )CRSP) Structural algorithmic dates for a turn and price targets possible.
We have Classic Divergence on the MACD and Hidden Bullish Divergence on the RSI visible on the Weekly chart at the PCZ of a Bullish Gartley.
I would buy 40% at this price then if the price drops to $30-40 I'd buy the rest of the 60%
..aejfj;agiojagwejga ldak;jjewjg ag akgje;aijgwei vaie;jgijewpogjpwaeg wamaj;wefj pij;aewpfjoefj
I expect this to consolidate for the next few weeks.. probably into Q1/Q2 2022... leading to an eventual breakout to retest ATH
Crispr has been moving up since the Morning star break out on 13th December. Its further progress hinges on breaking the 83.46 resistance. It has tried piercing this resistance twice but failed. The resistance line at 83.46 and the upward support channel formed since 14th December at $70.37 is intersecting 83.46 on 28th December and CRSP has to break out before...
fresh breakout past a 5 month downtrend on CRSP ! if it holds and doesn't break back into the trend potential price targets for early 2022 area 98.31-113.89-129.47 like and follow for more 💘
CRSP It's time to update the idea. The care turned out to be very deep, although this option of leaving for zone 77 was supposed. Now we have dropped out of the channel a little, we will count for an error, we are also holding on to the ema200 during the week, we have formed hidden divergences during the week, taking into account the potential of the company, the...
Broke through the yellow downward trendline today with volume. The 50sma coincides with my gray trendline. Big upside if it can break through that.
Catalysts coming in 2022 and weekly trend changes based on heiken ashii candles, plus the bounce at 74+- which was prior resistance, plus analyst ratings make this an attractive buy for me at these levels.
Today we will take a look at CRISPR Therapeutics. Which are the main technical elements we can see here? a) The price is against a major Support/Resistance level, working since 2018. The price reaction on these zones tends to provide solid insight into future movements. b) Let's assume the price bounces on the current zone; what can we expect? - A...
-Covid ignored. We returned to the mean. -Purple area = consolidation zone = buy zone. CRISPR is a truely amazing discovery. Imagine if we could perfectly edit genes within 5 or 10 years. I don't think everyone understands how big this is. Good luck! Target 1 = double top, other 2 the fibonacci extensions. Edit: Don't buy before we stay above the 20MA.